Spinifex Pharmaceuticals Pty. Ltd.

Eli Lilly is determined to be a key player in a future non-opioid pain treatment market, and has in-licensed a novel oral compound from Belgium’s Confo Therapeutics , paying $40m upfront in a deal w

Grey Wolf Therapeutics, Ltd. has closed an oversubscribed $49m series B financing in a bid to hasten its lead program to the clinic and validate its novel approach to unmasking tumors with poor visib

By Tamra Sami Australia’s biotechnology industry has grown roughly 3% over the last decade, but it has been significantly outpaced by its international peers by more than 200%, according to a new rep

Quartet Medicine Inc. 400 Technology Square Floor 10 Cambridge, MA 02139 Phone: +1 (857) 201-2780 Web Site: www.quartetmedicine.com Contact: Kevin Pojasek, PhD, President & CEO Industry Segment